Mesenteric ischemia in giant cell arteritis: 6 Cases and a systematic review

Journal of Rheumatology

Volumn 34, Issue 8, 2007, Pages 1727-1732

  Sujobert, Pierre ^a   Fardet, Laurence ^a   Marie, Isabelle ^b   Duhaut, Pierre ^c   Cohen, Pascal ^d   Grange, Claire ^e   Gaultier, Jean Baptiste ^e   Arrivé, Lionel ^a   Cabane, Jean ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b Hôpital de Rouen   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d Hopital Cochin ^*  (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Giant cell arteritis; Mesenteric ischemia

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIAGNOSTIC IMAGING; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; FRANCE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; ISCHEMIA; LAPAROTOMY; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEDLINE; MESENTERIC ARTERY; MESENTERY DISEASE; MESENTERY ISCHEMIA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYMPTOM; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; GIANT CELL ARTERITIS; HUMANS; ISCHEMIA; MALE; MESENTERY; MIDDLE AGED; PROGNOSIS;

EID: 34547932901     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
2. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975;83:806-12.
3. Arguedas MR, Linder JD. Giant cell arteritis and intestinal angina. Dig Dis Sci 2000;45:2363-4.
4. Conri P, Legendre P, Sassoust G, Conri C, Midy D, Baste JC. Chronic mesenteric ischemia and temporal arteritis [French]. J Ma Vasc 2003;28:89-91.
5. Evans DC, Murphy MP, Lawson JH. Giant cell arteritis manifesting as mesenteric ischemia. J Vasc Surg 2005;42:1019-22.
6. Evans DJ, Wilkins MJ, Wazir JF, Rosin D. Extracranial giant cell arteritis. J Roy Coll Surg Edinburgh 1998;43:207-8.
7. Fontaney F, Dacosta A, Mosnier JF, et al. Inflammatory pseudotumor of the intestine caused by necrotizing vasculitis in the course of Horton disease [French]. Gastroenterol Clin Biol 1995;19:940-3.
8. Hamrin B, Jonsson N, Landberg T. Involvement of large vessels in polymyalgia arteritica. Lancet 1965;33:1193-6.
9. Hassan WU, Daymond TJ. Small bowel infarction in association with giant cell arteritis. Br J Rheumatol 1993;32:942.
10. Houdent C, Hemet J, Delgove H, Lhuintre JP, Wolf LM. Giant cell arteritis with mesenteric localization. Case report [French]. Rev Med Interne 1981;2:51-3.
11. Kalbermatter V, Laudanno C, Bagilet D, Diab M, Gimenez D, Serra F. Intestinal infarct caused by giant cell arteritis [Spanish]. Medicina B Aires 1999;59:86-9.
12. Krant JD, Ross JM. Extracranial giant cell arteritis restricted to the small bowel. Arthritis Rheum 1992;35:603-4.
13. Lockhart ME, Robbin ML. Case 58: giant cell arteritis. Radiology 2003;227:512-5.
14. Patterson A, Scully C, Barnard N, Griffiths MJ, Eveson JW, Novelli M. Necrosis of the tongue in a patient with intestinal infarction. Oral Surg Oral Med Oral Pathol 1992;74:582-6.
15. Phelan MJ, Kok K, Burrow C, Thompson RN. Small bowel infarction in association with giant cell arteritis. Br J Rheumatol 1993;32:63-5.
16. Serradell S, Laiz A, Castano C, de Llobet JM. Usefulness of angioplasty in a patient with biopsy-proven giant cell arteritis and severe stenosis of the superior mesenteric artery. J Rheumatol 2006;33:1204-5.
17. Smith JA, O'Sullivan M, Gough J, Williams BD. Small-intestinal perforation secondary to localized giant-cell arteritis of the mesenteric vessels. Br J Rheumatol 1988;27:236-8.
18. Sorensen S, Lorenzen I. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients. Acta Med Scand 1977;201:207-13.
19. Srigley JR, Gardiner GW. Giant cell arteritis with small bowel infarction. A case report and review of the literature. Am J Gastroenterol 1980;73:157-61.
20. Stanley D, Henderson D, Harris S. Giant cell arteritis associated with pericarditis and large vessel disease. Aust NZ J Med 1991;21:353-5.
21. Stenwig JT. Intestinal gangrene due to giant-cell arteritis. Report of a case. J Oslo City Hospitals 1976;26:49-55.
22. Tozzi N, Kharsa G, Olivier A. Giant cell arteritis and necrosis of the small intestine. Report of a case [French]. J Mal Vasc 1998;23:293-6.
23. Trimble MA, Weisz MA. Infarction of the sigmoid colon secondary to giant cell arteritis. Rheumatology Oxford 2002;41:108-10.
24. Tsuyuoka R, Takahashi T, Shinoda E, et al. Intestinal perforation in temporal arteritis, associated with paroxysmal nocturnal hemoglobinuria. Int Med 1996;35:159-61.
25. Ostberg G. Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand 1972;533:135-59.
26. Bongartz T, Matteson EL. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 2006;18:10-7.
27. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3522-31.
28. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
29. Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000;18 Suppl 20:S43-8.
30. Nordborg E, Nordborg C. Giant cell arteritis: strategies in diagnosis and treatment. Curr Opin Rheumatol 2004;16:25-30.
31. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003;139:505-15.
32. Ljungstrom KG, Strandberg O, Sandstedt B. Infarction of the small bowel caused by giant cell arteritis. Case report. Acta Chir Scand 1989;155:361-3.
33. Ross Russel R. Giant cell arteritis. A review of 35 cases. Q J Med 1959;112:471-89.
34. Simkin PA, Healey LA. Giant cell arteritis with polymyalgia rheumatica, loss of vision, and abdominal symptoms occurring during a four year course. Arthritis Rheum 1969;12:147-51.
35. Duhaut P, Pinede L, Demolombe-Rague S, et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Arterite a Cellules Geantes. Arthritis Rheum 1998;41:1960-5.
36. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine 2004;83:342-7.
37. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. New Engl J Med 2002;347:261-71.
38. Harward TR, Smith S, Seeger JM. Detection of celiac axis and superior mesenteric artery occlusive disease with use of abdominal duplex scanning. J Vasc Surg 1993;17:738-45.
39. Salvarani C, Silingardi M, Ghirarduzzi A, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 2002;137:232-8.
40. Agard C, Ponge T, Hamidou M, Barrier J. Role for vascular investigations in giant cell arteritis. Joint Bone Spine 2002;69:367-72.
41. Staunton H, Stafford F, Leader M, O'Riordain D. Deterioration of giant cell arteritis with corticosteroid therapy. Arch Neurol 2000;57:581-4.
42. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998;41:1497-504.
43. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 1993;100:550-5.
44. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994;101:1779-85.
45. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003;110:1204-15.
46. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50:1332-7.
47. Brack A, Geisler A, Martinez-Taboada VM, Younge BR, Goronzy JJ, Weyand CM. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997;3:530-43.
48. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
49. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-91.
50. Weyand CM, Kaiser M, Yang H, Younge B, Goronzy JJ. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002;46:457-66.
51. Cid MC, Font C, Oristrell J, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998;41:26-32.
52. Liozon E, Herrmann F, Ly K, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 2001;111:211-7.
53. Nesher G, Berkun Y, Mates M, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine 2004;83:114-22.
54. Hernandez-Rodriguez J, Segarra M, Vilardell C. et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003;107:2428-34.